Covered recipient · General Payments record
DAVID X SILKINER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,726.20
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.28 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $42.45 | 2 |
| Lilly USA, LLC | $37.70 | 2 |
| Novo Nordisk AS | $31.96 | 2 |
| Daiichi Sankyo Inc. | $21.30 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.52 | 1 |
| PFIZER INC. | $17.21 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.64 | 1 |
| Exact Sciences Corporation | $15.88 | 1 |
| DEXCOM, INC. | $15.70 | 1 |
| ABBVIE INC. | $14.79 | 1 |
| Amgen Inc. | $14.57 | 1 |
| Dynavax Technologies Corporation | $12.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.79 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106102326 | CMS |
| Amgen Inc. | $14.57 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117383172 | CMS |
| Astellas Pharma US Inc | $14.58 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268198 | CMS |
| Astellas Pharma US Inc | $27.87 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139282426 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117976744 | CMS |
| Daiichi Sankyo Inc. | $21.30 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089483175 | CMS |
| Dexcom, Inc. | $15.70 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295431 | CMS |
| Dynavax Technologies Corporation | $12.56 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082146795 | CMS |
| Exact Sciences Corporation | $15.88 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114899374 | CMS |
| Lilly USA, LLC | $21.74 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138237 | CMS |
| Lilly USA, LLC | $15.96 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136150867 | CMS |
| Novo Nordisk Inc | $16.85 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097337624 | CMS |
| Novo Nordisk Inc | $15.11 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096877863 | CMS |
| PFIZER INC. | $17.21 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131838560 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.52 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144592158 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.